Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test. The EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy) by Zorzi, Manuel et al.
ORIGINAL ARTICLE
Quality of colonoscopy in an organised colorectal
cancer screening programme with immunochemical
faecal occult blood test: the EQuIPE study
(Evaluating Quality Indicators of the Performance
of Endoscopy)
Manuel Zorzi,1 Carlo Senore,2 Filippo Da Re,3 Alessandra Barca,4 Luigina Ada Bonelli,5
Renato Cannizzaro,6 Renato Fasoli,7 Lucia Di Furia,8 Emilio Di Giulio,9
Paola Mantellini,10 Carlo Naldoni,11 Romano Sassatelli,12 Douglas Rex,13
Cesare Hassan,14 Marco Zappa,15 the Equipe Working Group
For numbered affiliations see
end of article.
Correspondence to
Dr Manuel Zorzi,
Veneto Tumour Registry,
Passaggio Gaudenzio 1,
Padova (PD) 35131, Italy;
manuel.zorzi@regione.veneto.it
Received 2 July 2014
Revised 8 August 2014
Accepted 31 August 2014
Published Online First
16 September 2014
To cite: Zorzi M, Senore C,
Da Re F, et al. Gut
2015;64:1389–1396.
ABSTRACT
Objectives To assess variation in the main
colonoscopy quality indicators in organised colorectal
cancer (CRC) screening programmes based on faecal
immunochemical test (FIT).
Design Data from a case-series of colonoscopies of
FIT-positive subjects were provided by 44 Italian CRC
screening programmes. Data on screening history,
endoscopic procedure and histology results, and
additional information on the endoscopy centre and the
endoscopists were collected. The adenoma detection rate
(ADR) and caecal intubation rate (CIR) were assessed for
the whole population and the individual endoscopists.
To explore variation in the quality indicators, multilevel
analyses were performed according to patient/centre/
endoscopist characteristics.
Results We analysed 75 569 (mean age: 61.3 years;
men: 57%) colonoscopies for positive FIT performed by
479 endoscopists in 79 centres. ADR ranged from
13.5% to 75% among endoscopists (mean: 44.8%).
ADR was associated with gastroenterology specialty (OR:
0.87 for others, 95% CI 0.76 to 0.96) and, at the
endoscopy centre level, with the routine use of sedation
(OR: 0.80 if occasional (<33%); 95% CI 0.64 to 1.00)
and availability of screening-dedicated sessions (OR:
1.35; 95% CI 1.11 to 1.66). CIR ranged between
58.8% and 100% (mean: 93.1%). Independent
predictors of CIR at the endoscopist level were the yearly
number of screening colonoscopies performed (OR: 1.51
for endoscopists with >600 colonoscopies; 95% CI 1.11
to 2.04) and, at the endoscopy centre level, screening-
dedicated sessions (OR: 2.18; 95% CI 1.24 to 3.83) and
higher rates of sedation (OR: 0.47 if occasional; 95% CI
0.24 to 0.92).
Conclusions The quality of colonoscopy was affected
by patient-related, endoscopist-related and centre-related
characteristics. Policies addressing organisational issues
should improve the quality of colonoscopy in our
programme and similar programmes.
INTRODUCTION
Colorectal cancer (CRC) is a major cause of morbid-
ity and mortality.1 2 CRC screening with biannual
faecal occult blood test (FOBT) has been shown to
reduce CRC mortality,3 4 and immunochemical-
FOBT (faecal immunochemical test, FIT) has been
shown to be more accurate than guaiac-FOBT
Significance of this study
What is already known on this subject?
▸ Organised colorectal cancer screening
programmes with immunochemical faecal test
have been implemented in Europe.
▸ The quality of colonoscopy is critical for the
overall success of these organised programmes.
▸ Adenoma detection rate and caecal intubation
rate are the most important indicators of the
quality of colonoscopy.
What are the new findings?
▸ In the Italian screening programme with
immunochemical faecal test, the overall level of
quality of colonoscopy was adequate, with the
adenoma detection and caecal intubation rates
being 45% and 93%, respectively.
▸ There was substantial variation among the
endoscopists in both indicators. This variation
was explained by at least three levels of
predictors, namely at per-patient,
per-endoscopist and per-centre levels.
▸ Gastroenterology specialty, sedation and the
availability of screening-dedicated sessions
were associated with the adenoma detection
rate. Sedation, the availability of screening-
dedicated sessions and the volume of screening
colonoscopies were associated with the caecal
intubation rate.
How might it impact on clinical practice in
the foreseeable future?
▸ Policies addressing organisational issues, such as
sedation, the availability of screening sessions
and endoscopist retraining are likely to improve
the overall quality of colonoscopy in this setting.
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(g-FOBT) for advanced neoplasia.5 6 An organised screening pro-
gramme with FIT has been implemented in Italy7 as well as in
other European countries and Australia.8 The efficacy of an
FOBT-based screening programme ultimately depends on the
accuracy of post-FOBT colonoscopy. High variability in the
adenoma detection rate (ADR) between endoscopists has been
reported, and ADR predicts the risk of postcolonoscopy interval
cancer.9–14 The indication of positive FOBT is an independent
predictor of interval cancer after colonoscopy,15 reflecting the
high prevalence of advanced neoplasia in FIT-positive patients
and underscoring the need for effective detection at colonoscopy
in this population.5 16 The caecal intubation rate (CIR) is also an
important indicator of colonoscopy quality, as lower rates are
associated with increased risk of postcolonoscopy cancer.12 15
A previous study on 36 460 colonoscopies performed within
the National Health Service Bowel Cancer Screening
Programme with g-FOBT demonstrated a marked variation in
ADR among 177 endoscopists, ranging between 21.9% and
59.8%.17 However, endoscopist-related/centre-related predictors
of variable detection were not explored at multivariate ana-
lysis.17 Predictors of CIR within an organised screening pro-
gramme have not been assessed, and no previous study has
reported detection variation in a programme based on FIT.
We assessed variation in colonoscopy quality among the
endoscopists operating within the organised screening pro-
gramme with FIT in Italy, and identified endoscopist and
centre-related factors that affect ADR and CIR.
MATERIALS AND METHODS
CRC-organised screening programme in Italy
The organised screening programme with FIT in Italy is per-
formed at a regional level. Screening centres in each region are
responsible for inviting eligible subjects. In 2010, overall 107
centres were active in Italy, with a target population of 9 493 250
50-year-old to 69-year-old persons. Programs invite people
(mostly aged 50–69 years) to perform a single-sample FIT on a
biennial basis; only in the Piedmont region and in the province of
Verona, people aged 58 or 60 years (Verona) are offered screening
with flexible sigmoidoscopy (FS) once in the lifetime, while bien-
nial FIT is offered until age 69 years to those who are not screened
with FS. Due to heterogeneity in resources, the screening pro-
gramme has been mainly implemented in the North-Central
Italian regions.7 Individuals with a positive FIT result
(cut-off=100 ng HB/mL buffer) are offered colonoscopy. Persons
attending colonoscopy are required to give preprocedure consent
and are given explicit instructions on bowel preparation. Sedation
and bowel preparation are performed in accordance with local
guidelines, which vary among screening centres. All demographic,
colonoscopic and histopathological data are recorded by the
screening centre on a regional database. There is no established
accreditation programme or examination and/or audit, for an
endoscopist to practise in the organised screening programme.
Study population
All the organised CRC screening programmes in Italy were
invited to participate in this study. Each participating pro-
gramme was required to provide individual data about all colon-
oscopies carried out within the regional screening programmes
during 2010. Depending on data availability, individual pro-
grammes, or regions, could provide additional data referring to
other calendar years.
For each patient, demographic information, screening history
and colonoscopic procedure and histology results were collected
on a standard precoded electronic form. Information
concerning the endoscopy centre (EC) and the endoscopists
were collected based on a standard form (table 1).
In order to reduce variation in the baseline prevalence of
lesions and to avoid double-counting of adenomas, only first
colonoscopies following a positive FIT were included in the
analysis.
Study variables
At the patient level, individual colonoscopy data routinely
included the following information: (1) patient demographics,
(2) number of previous FIT examinations, (3) quality of bowel
preparation (endoscopist’s judgement, aggregated as adequate/
inadequate), (4) sedation (conscious/deep/none), (5) caecal
intubation and (6) number and characteristics of diagnosed
polyps/masses, including morphology, localisation, size and hist-
ology. In detail, due to the heterogeneity of bowel preparation
scales adopted in the different programmes, participating
centres were asked to record bowel cleansing, according to a 4-
categories scale (excellent, good, fair, poor) that was subse-
quently aggregated as adequate (excellent/good) and inadequate
(fair/poor).
At the endoscopist level, we collected (1) demographics, (2)
specialty, (3) number of years of activity as endoscopist (≤5, 6–9,
≥10-year experience), (4) number of screening colonoscopies
performed in 2010 (≤100, 101–180, >180) and (5) overall
number of colonoscopies performed in 2010 (≤300, 301–600,
>600).
At the centre level, we collected the following indicators: (1)
use of screening-dedicated sessions for FIT-positive colonos-
copies (ie, scheduled outside daily non-screening endoscopy),
(2) use of sedation (<33%, 33%–66% and >66% of colonos-
copies), (3) adoption of routine quality assurance procedures
(ie, monitoring of postprocedural complications, documentation
of caecal intubation, scale used to assess quality of bowel prepar-
ation). Based on the 2010 data, we also calculated the number
of post-FIT-positive colonoscopies performed in 2010 (≤300,
301–600, 601–800 and >800).
Study end-points and statistical analysis
In order to assess the variability in the detection rate among
individual endoscopists, we aggregated the diagnosis of the fol-
lowing findings at a per-patient level: (1) polyp (polyp detection
rate, PDR), (2) ADR, (3) advanced adenoma detection rate (an
adenoma with villous component >20%, or high-grade dyspla-
sia, or size ≥1 cm—AADR).
We used linear regression to assess correlation between ADR
on one side and PDR/AADR on the other. In order to identify
possible predictors of ADR, we evaluated the association
between several variables and ADR. These variables were
Table 1 Explicative variables for the adenoma detection rate
Patient
characteristics
Endoscopist
characteristics
Endoscopic Centre
characteristics
▸ Sex
▸ Age
▸ FIT round
▸ Bowel
cleansing
▸ Caecal
intubation
▸ Sex
▸ Age
▸ Specialty
▸ Number of years of
activity as endoscopist
▸ Number of screening TCs
performed in 2010
▸ Overall number of TCs
performed in 2010
▸ Use of dedicated
sessions
▸ Use of sedation
▸ Number of screening TCs
performed in 2010
FIT, faecal immunochemical test; TC, total colonoscopy.
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classified as characteristics of (1) patient, (2) EC and (3) endos-
copist (table 1). Sedation was considered as an organisation
modality of the EC.
We initially explored the relationship between each group of
variables and ADR by univariate analysis. The variables with a
significant association with detection were included in a multi-
variate model with SE correction. Finally, the variables that
remained associated with detection rates were included in a final
multilevel model (with Laplace approximation), that accounted
for the intralevel and interlevel variability at the following
levels: region, EC and endoscopist. The Variance Partition
Coefficient was used to quantify the proportion of the residual
outcome variation attributable to unobserved characteristics of
each level of the model.18 19
We performed the same analysis for predictors of CIR,
excluding colonoscopies with inadequate cleansing. Indeed, the
examination might have been interrupted already during the
insertion phase in these cases, if the endoscopist had judged
the preparation inadequate, since the colonoscopy needed to be
repeated in any case. However, we also added inadequate
cleansing as a putative predictor of CIR in a secondary analysis.
All reported p values are two sided. A p value of <0.05 was
considered significant. All analyses were performed using Stata
V.10.0 statistical package.
RESULTS
Study population
Overall, 44 programmes from eight regions of Northern and
Central Italy took part in the study, with an overall target popu-
lation of 403 646 950 69-year-old persons. All programmes
used the OC-Hemodia latex agglutination test, developed with
the OC-Sensor Diana or OC-Sensor Micro instrument (Eiken,
Tokyo, Japan). These programmes provided individual data on
93 249 colonoscopies included in the CRC database in 2010.
Of these, 75 569 (81%) were for positive FIT, the remaining
being for postpolypectomy surveillance (n=12 902, 13.8%),
completion of previously incomplete colonoscopies (n=2483,
2.7%) or other screening-related indications (n=2295, 2.5%).
Thus, the final study population consisted of 75 569 patients
(mean age: 61.3 years; men: 57%). The geographical distribu-
tion of the study population is provided in table 2.
Patient characteristics
Overall, 43 430 (57.5%) positives were at the first FIT examin-
ation, and the remaining patients had one or more previous
negative FIT exams (table 2). Sedation was applied in 81.7% of
the cases. When reported (n=25 760, 41.7%), it was conscious
sedation in most cases (89.6%). Caecal intubation was achieved
in 93.1% of the patients. Colon cleansing was rated adequate in
92.7% of the patients.
Endoscopist characteristics
The endoscopist’s characteristics were available for 73% of
endoscopists (350/479), accounting for 85.6% of (64 686/
75 569) colonoscopies. In the remaining cases, the endoscopist’s
identification code was recorded, but his/her characteristics were
not provided. As shown in table 3, 76.5% of the exams were
performed by male endoscopists, and 42.9% by operators
between 50 and 59 years of age. The majority of the colonos-
copies (73.8%) were performed by gastroenterologists, with the
remaining by surgeons or other specialties. Distribution of
endoscopists/colonoscopies according to experience/volume of
procedures is provided in table 3. More than 63% endoscopists
had over 10 years of experience.
ECs’ characteristics
EC information was available for 79 centres, accounting for 88%
(66 539/75 569) of the study colonoscopies. In 81% of the 79
centres, colonoscopy for positive FITs was performed in dedi-
cated sessions, accounting for 87.5% of the procedures (table 4).
Sedation was used in >66% of colonoscopies in 60 ECs (75%),
accounting for 51 068 (82.4%) procedures. Sedation was per-
formed in 33%–66% and <33% of colonoscopies in 11 (13.8%)
and 9 (11.3%) centres, respectively. Distribution of centres
according to the volume of yearly screening colonoscopies and
endoscopist specialty is reported in table 4.
Adenoma detection rates
At a per-patient analysis, at least one polyp/adenoma/advanced
adenoma was in 59.3%, 44.8% and 29% of the procedures.
Table 2 Main characteristics of the study population and of the
colonoscopies included in the study
Variable Number Per cent
Overall 75 569 100
Region
Emilia Romagna 15 891 21.0
Lazio 3268 4.3
Liguria 487 0.6
Marche 2584 3.4
Piemonte 891 11.8
Toscana 5024 6.7
Trento 1171 1.6
Veneto 38 234 50.6
Sex
Male 42 965 56.9
Female 32 603 43.1
Missing 1 0
Age (years)
50–55 13 241 17.5
55–59 13 842 18.3
60–64 21 163 28
65+ 27 313 36.1
Missing 10 0
FIT round
1st 43 430 57.5
2nd 19 149 25.3
3rd 9516 12.6
≥4th 2948 3.9
Missing 526 0.7
Bowel cleansing
Adequate 70 026 92.7
Inadequate 5218 6.9
Missing 325 0.4
Caecal intubation
Yes 70 374 93.1
No 4946 6.6
Missing 249 0.3
Sedation
Done* 36 013 47.7
Conscious 23 090 30.6
Propofol 2670 3.5
None 13 720 18.2
Missing 76 0.1
*Not specified whether conscious or with propofol.
FIT, faecal immunochemical test.
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ADR of single endoscopists was strongly correlated with both
PDR and AADR (figure 1).
ADR ranged from 13.5% to 75% among endoscopists who
performed at least 30 colonoscopies, the 10th and 90th percent-
ile of ADR among endoscopists being 31.9% and 60%.
Regarding patient characteristics, ADR was higher in men,
those examined in the first FIT screening round, those with
adequate bowel preparation, and it showed a trend toward
increasing with older age (table 5).
ADR was associated with endoscopist specialty, but not with
endoscopist years of experience or the volume of activity. ADR
was higher in centres with dedicated sessions and in those that
routinely used sedation.
In the multilevel analysis (table 6), ADR was associated with
the following factors: (1) Patient-related, male sex (OR of
women: 0.58, 95% CI 0.56 to 0.60), age (OR: 1.02 per 1-year
increase, 95% CI 1.02 to 1.03), 1st FIT round (OR: 0.78 per
1-round increase, 95% CI 0.75 to 0.81), complete colonoscopy
(OR: 2.52, 95% CI 2.32 to 2.75) and an adequate preparation
(OR: 1.53, 95% CI 1.42 to 1.65); (2) Endoscopist-related,
gastroenterology specialty (OR of other specialties: 0.87, 95%
CI 0.76 to 0.96); (3) EC-related, routine use of sedation (OR of
occasional (<33%) use: 0.80, 95% CI 0.64 to 1.00) and
screening-dedicated session (OR: 1.35, 95% CI 1.11 to 1.66).
The residual variation was 1.1% both at the endoscopist and
EC levels; no residual variability was observed at the region level.
When restricting the analysis to subjects with complete colon-
oscopy (data not shown) the predictive role of the other vari-
ables did not show substantial changes.
Caecal intubation rate
Overall, the caecum was reached in 93.1% of colonoscopies.
CIR was slightly lower in female patients and in those examined
in their first FIT round, and it decreased with age (table 5). CIR
dropped to 71.3% in cases with inadequate bowel cleansing.
CIR was higher for endoscopists with more than 5 years of
experience, and in those performing a high volume of exams—
both screening and overall. CIR ranged between 58.8% and
100% among endoscopists who had performed at least 30 col-
onoscopies (10th–90th percentile: 83.3% and 99.7%).
Among the organisational characteristics of ECs, CIR was
higher when the exam was performed in dedicated sessions
(94.3%) than in colonoscopies without dedicated sessions
(90.6%), in centres with a higher proportion of sedated exams
(94.5%) than in those performing sedation in <33% of colon-
oscopies and in those with a higher yearly volume of colonos-
copies, compared with those with lower volumes.
At the multilevel analysis, CIR was lower in women (OR of
women: 0.72, 95% CI 0.66 to 0.78), older age (OR per 1-year
increase: 0.97, 95% CI 0.97 to 0.98), while it was higher in subjects
at subsequent screening round (OR per 1-round increase: 1.42,
95% CI 1.27 to 1.58) (table 7). Among endoscopist characteristics,
caecal intubation was associated with the yearly number of screen-
ing colonoscopies performed (OR 1.38, 95% CI 1.04 to 1.82 and
1.51, 95% CI 1.11 to 2.04 for endoscopists with 301–600 and
>600 colonoscopies, respectively). Screening-dedicated sessions
were associated with a doubling of completion of colonoscopy too
(OR: 2.18, 95% CI 1.24 to 3.83), while low rates of sedation
reduced CIR by more than 50% (OR: 0.47, 95% CI 0.24 to 0.92).
The residual unexplained variability for CIR was 2.4%, 8.5% and
7.1% for the region, EC and endoscopist levels, respectively.
When persons with inadequate bowel cleansing were included,
the predictive role of the other variables did not show substantial
changes (data not shown), while adequate cleansing was strongly
associated with CIR (OR 9.94, 95% CI 9.07 to 10.9).
DISCUSSION
Our data indicate that variation in quality of colonoscopy per-
formance in an organised screening programme with FIT is
Table 4 Main characteristics of the endoscopic centres and FIT+
colonoscopies performed by endoscopic centres with different
characteristics
Variable
Number of
endoscopic centres Per cent Colonoscopies (%)
Screening-dedicated sessions
Yes 64 81.0 87.5
No 15 19.0 12.6
Colonoscopy with sedation/all colonoscopies
<33% 8 10.2 7.1
33%–66% 11 13.9 10.5
>66% 60 75.9 82.4
Screening colonoscopies performed in 2010
≤300 54 68.4 26.5
301–600 12 15.2 26.0
601–800 7 8.9 26.9
>800 6 7.6 20.5
Screening-dedicated sessions are defined as endoscopic session restricted to
screening-related colonoscopies.
FIT, faecal immunochemical test.
Table 3 Main characteristics of the study endoscopists (n=350)
and FIT+colonoscopies performed by the different endoscopists
Variable
Number of
endoscopists Per cent Colonoscopies (%)
Sex
Male 253 72.3 76.5
Female 97 27.7 23.5
Age (years)
30–39 71 20.3 16.4
40–49 89 25.4 25.0
50–59 135 38.6 42.9
≥60 44 12.6 13.8
Missing 11 3.1 1.9
Specialty
Gastroenterology 253 72.3 73.8
Surgery 77 22.0 21.2
Other 13 3.7 3.6
Missing 7 2.0 1.4
Experience (years)
≤5 43 12.3 7.0
6–9 56 16.0 15.8
≥10 222 63.4 70.1
Missing 29 8.3 7.2
Screening colonoscopies performed in 2010
≤ 100 281 80.3 50.9
101–180 47 13.4 25.7
>180 22 6.3 23.4
Overall colonoscopies performed in 2010
≤300 76 21.7 10.1
301–600 120 34.3 31.5
>600 123 35.1 54.5
Missing 31 8.9 3.9
FIT, faecal immunochemical test.
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largely explained by relatively simple endoscopist and organisa-
tional characteristics. We showed that dedicated colonoscopy
sessions and systematic use of sedation predicted higher ADR
and CIR in our study population. Additionally, the CIR of indi-
vidual endoscopists is predicted by the yearly volume of colon-
oscopies performed in the programme, and gastroenterologists
have higher ADRs.
The very low proportion of the total variance of each level
suggests that nearly all the variability in ADR between endosco-
pists and ECs is explained by the factors included as fixed
effects in the model. The absence of residual variability at the
regional level might be related to the very low variability in the
incidence rate in the areas involved in the study.20
The proportion of variability in CIR attributable to unob-
served characteristics was lower than 10% both between endos-
copists and between ECs.
This is the first study assessing the quality of colonoscopy—as
measured by ADR and CIR—within an organised screening pro-
gramme with FIT. While the mean values reported in our
cohort indicate an adequate average quality of colonoscopy
(mean ADR and CIR of 45% and 93%, respectively), we also
identified substantial variability among endoscopists, the ADR
and CIR ranging between 13% and 75%, and 59% and 100%,
respectively. Our data, based on 75 569 FIT-positive colonos-
copies, confirm the large variation in ADR observed in a cohort
of 36 460 g-FOBT-positive patients in the UK, with the
endoscopist-ADR and CIR ranging between 22% and 60%, and
between 76% and 100%, respectively.17
Additionally, our multilevel analysis showed that ADR and
CIR should be considered as multidimensional quality indica-
tors, depending on at least three different levels of the screening
process, namely the patient, the endoscopist and the centre. Of
note, we were able to identify significant predictors at each of
these levels. We showed that age, sex and round of FIT are each
independent patient-related predictive factors of neoplasia
detection. This differed from the g-FOBT setting, where round
of screening did not affect endoscopist ADR.17 This difference
could be related to the higher sensitivity of FIT for large aden-
omas compared with g-FOBT, resulting in a net decrease in
ADR between the first and subsequent rounds, as already
showed in the Dutch and Italian studies.21 22 Similarly, we
showed that female sex was strongly associated with a lower
CIR, in agreement with a previous study.23 Additionally, we
showed a dramatic impact of the level of cleansing on ADR.
This is different from the previous UK g-FOBT-based study
where, unexpectedly, no difference in ADR according to level of
cleansing was shown.22 Our result is in line with several studies,
relating adequate preparation to higher ADR.24 25 This finding
underscores the value of implementing policies to improve
cleansing within organised screening programmes. In particular,
all barriers to split regimens should be removed, considering the
favourable effect of this simple adjustment on cleansing level
and ADR.26 27 Inadequate preparation was also associated with
a substantially lower CIR, in agreement with previous
reports.28 29
GI-specialty was an independent predictor of ADR at an
endoscopist’s level. Despite the association between
endoscopist-specialty and ADR not having been explored previ-
ously,17 30 31 GI-specialty has been consistently related with a
reduced risk of postcolonoscopy interval cancer.10 32–35 No
study that examined this issue has found colonoscopy by non-
gastroenterologists to be as or more effective in preventing CRC
compared with colonoscopy by gastroenterologists.10 32–36 One
potential conclusion is to transfer the performance of colonos-
copy from non-gastroenterologists to gastroenterologists.
A recent study found that substantial differences in polyp
detection existed between gastroenterology and surgical trainees
in the same institution.37 We also showed an association
between the volume of screening colonoscopy and the CIR,
underlining the relevance of an adequate volume of procedures
on the overall quality of colonoscopy.
Third, we showed that organisational features of ECs affect
ADR and CIR in organised screening programmes.
In particular, sessions dedicated to colonoscopy in
FIT-positive patients were associated with better performance
for both quality measures. To our knowledge, this variable has
not been examined in previous series. Dedicated sessions may
reduce distractions for endoscopists, allow scheduling adjust-
ments for the relatively heavy polyp burdens of FIT-positive
patients, and encourage specialisation and development of
expertise in colonoscopy and polypectomy, such as is commonly
perceived to occur in endoscopy lists concentrated on proce-
dures such as endoscopic ultrasound, endoscopic retrograde
cholangiopancreatography, treatment of Barrett’s oesophagus,
and surveillance of inflammatory bowel disease. Dedicated ses-
sions for FIT-positive patients are attractive from the perspective
of being relatively simple to arrange, requiring only reallocation
of resources rather than new medical or economic and logistic
resources.
The large sample size allowed us to show an association
between the use of sedation, and higher ADR and CIR. The
association between sedation and CIR shown by our analysis is
in agreement with previous reports.26 38 The evidence of the
effect of any sedation on ADR is limited and inconsistent. Our
findings are in line with a previous nationwide Italian study
reporting an association between sedation and higher PDR in a
cohort of unselected patients who underwent sedated colonos-
copy in 55% of the cases.29 On the other hand, effect of sed-
ation on ADR was found in the g-FOBT-based UK cohort, as
well as in other screening studies.24 38–41 The high proportion
of sedated exams in some of these studies (ie, >95% in the
Spanish study27) might explain the lack of an association
between sedation and ADR. The proportion of unsedated
exams, as well as the interendoscopist variability in sedation use,
Figure 1 Linear regression of the
polyp detection rate and advanced
adenoma detection rate with the
adenoma detection rate of single
endoscopists.
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Table 5 Adenoma detection rate (%) and caecal intubation rate
(%) per patient, endoscopist and centre levels, with 95% CIs
Variable
Adenoma detection rate Caecal intubation rate
% (95%CI) Number % (95%CI) Number
Overall 44.8 (44.5 to 45.2) 75 569 93.4 (93.3 to 93.6) 75 320
Patient characteristics
Sex
Male 50.6 (50.1 to 51.0) 42 823 94.1 (93.9 to 94.4) 42 833
Female 37.3 (36.7 to 37.8) 32 462 92.5 (92.2 to 92.8) 32 486
Age (years)
50–54 39.4 (38.8 to 40.5) 19 416 94.7 (94.2 to 95.1) 12 358
55–59 44.6 (43.3 to 44.9) 12 113 94.2 (93.9 to 94.6) 13 778
60–64 46.8 (45.8 to 47.1) 18 742 93.3 (93.0 to 93.7) 21 103
65+ 46.8 (46.1 to 47.3) 25 005 92.5 (92.2 to 92.8) 27 233
FIT round
1st 47.2 (46.7 to 47.6) 40 193 92.8 (92.6 to 93.0) 43 274
2nd 42.7 (42.0 to 43.4) 19 149 94.3 (94.0 to 94.6) 19 074
3rd 40.4 (39.4 to 41.4) 9516 94.6 (94.1 to 95.0) 9507
≥4th 40.5 (38.7 to 42.2) 2948 94.7 (93.9 to 95.5) 2942
Bowel cleansing
Adequate 45.8 (45.4 to 46.1) 69 765 95.0 (94.9 to 95.2) 69 975
Inadequate 33.7 (32.2 to 34.7) 5195 71.9 (70.4 to 83.0) 5169
Endoscopist characteristics
Sex
Male 44.7 (44.2 to 45.1) 49 492 93.9 (93.7 to 94.1) 49 416
Female 46.8 (46.0 to 47.5) 15 194 94.3 (94.0 to 94.7) 15 180
Age (years)
30–39 47.1 (46.2 to 48.1) 10 602 94.0 (93.6 to 94.5) 10 589
40–49 45.3 (44.6 to 46.1) 16 169 94.1 (93.7 to 94.4) 16 158
50–59 44.7 (44.2 to 45.3) 27 775 93.9 (93.6 to 94.2) 27 745
≥60 43.6 (42.6 to 44.6) 8902 94.3 (93.9 to 94.8) 8879
Specialty
Gastroenterology 46.1 (45.6 to 46.5) 47 751 94.1 (93.9 to 94.3) 47 707
Surgery 42.7 (41.9 to 43.5) 13 723 93.9 (93.5 to 94.3) 13 693
Other 42.7 (40.7 to 44.7) 2337 94.1 (93.1 to 95.1) 2324
Experience (years)
≤5 45.8 (44.4 to 47.2) 4508 92.2 (91.4 to 93.0) 4507
6–9 44.2 (43.2 to 45.2) 10 219 94.4 (94.0 to 94.9) 10 216
≥10 45.2 (44.8 to 45.7) 45 333 94.0 (93.8 to 94.2) 45 273
Screening colonoscopies performed in 2010
≤100 45.6 (44.9 to 46.4) 17 479 92.4 (91.9 to 92.8) 17 435
101–180 46.2 (45.5 to 46.9) 18 102 94.7 (94.3 to 95.0) 18 082
>180 44.8 (44.2 to 45.5) 23 484 95.6 (95.3 to 95.8) 23 461
Overall colonoscopies performed in 2010
≤300 42.3 (41.1 to 43.5) 6545 90.3 (89.6 to 91.0) 6538
301–600 46.5 (45.8 to 47.2) 20 379 93.7 (93.4 to 94.0) 20 367
>600 45.0 (44.4 to 45.5) 35 236 95.0 (94.8 to 95.2) 35 201
Endoscopic centre characteristics
Screening-dedicated sessions
Yes 46.0 (45.6 to 46.4) 58 189 94.4 (94.2 to 94.6) 58 113
No 38.2 (37.1 to 39.2) 8350 89.9 (89.3 to 90.6) 8320
Colonoscopies with sedation/all colonoscopies
<33% 38.7 (37.3 to 40.1) 4830 86.8 (85.8 to 87.7) 4826
33%–66% 44.3 (43.1 to 45.4) 7165 93.4 (92.8 to 93.9) 7145
>66% 45.5 (45.1 to 45.9) 56 086 94.5 (94.3 to 94.7) 55 878
Screening colonoscopies performed in 2010
≤300 44.2 (43.5 to 45.0) 17 658 90.8 (90.4 to 91.2) 17 592
301–600 44.9 (44.2 to 45.6) 17 310 95.8 (95.5 to 96.1) 17 271
601–800 44.4 (43.7 to 45.2) 17 912 94.3 (94.0 to 94.6) 17 911
>800 47.0 (46.1 to 47.8) 13 659 94.5 (94.2 to 94.9) 13 659
FIT, faecal immunochemical test.
Table 6 Multilevel multivariate analysis to identify predictors of
the adenoma detection rate in the study population
OR 95% CI p Value
Patient characteristics
Sex
Male* 1.00 –
Female 0.58 0.56 to 0.60 <0.001
Age
1-year increase 1.02 1.02 to 1.03 <0.001
FIT round
1-round increase 0.78 0.75 to 0.81 <0.001
Caecal intubation
No* 1.00 –
Yes 2.52 2.32 to 2.75 <0.001
Bowel cleansing
Inadequate* 1.00 –
Adequate 1.53 1.42 to 1.65 <0.001
Endoscopist characteristics
Specialty
Gastroenterology* 1.00 –
Others 0.87 0.76 to 0.96 0.01
Endoscopic centre characteristics
Colonoscopy with sedation/all colonoscopies
>66%* 1.00 –
33%–66% 0.92 0.76 to 1.11 0.38
<33% 0.80 0.64 to 1.00 0.05
Screening-dedicated sessions
No* 1.00 –
Sì 1.35 1.11 to 1.66 0.001
*Reference category.
FIT, faecal immunochemical test.
Table 7 Multilevel analysis to identify predictors of caecal
intubation in the study population
OR 95% CI p Value
Patient characteristics
Sex
Male* 1.00 –
Female 0.72 0.66 to 0.78 <0.001
Age
1-year increase 0.97 0.97 to 0.98 <0.001
FIT round
1-round increase 1.42 1.27 to 1.58 <0.001
Endoscopist characteristics
Screening colonoscopies performed in 2010
≤300 1.00 –
301–600 1.38 1.04 to 1.82 0.026
>600 1.51 1.11 to 2.04 0.008
Endoscopic centre characteristics
Colonoscopies with sedation/all colonoscopies
>66% * 1.00 –
33%–66% 1.01 0.57 to 1.80 0.97
<33% 0.47 0.24 to 0.92 0.027
Screening-dedicated sessions
No* 1.00 –
Yes 2.18 1.24 to 3.83 0.007
Only colonoscopies with adequate cleansing.
*Reference category.
FIT, faecal immunochemical test.
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was similar in our study to the UK study.11 42 The lack of an
impact of sedation on ADR in the UK study after adjusting for
other factors suggests that technical and organisational factors
might reduce the need for sedation without undermining the
quality of the examination. The issue of whether sedation or the
level of sedation might affect ADR would represent an import-
ant research question, in particular, in a screening setting, where
patients might prefer to avoid potential risks related to
medications.
When considering the variables identified at each of the three
levels operating simultaneously, the impact on patients could be
dramatic. For example, non-GI endoscopists operating in
centres without sedation and screening-dedicated sessions had a
threefold lower ADR compared with GI-endoscopists working
in an opposite setting. ADR strongly predicts postcolonoscopy
interval cancer,13 14 33 an effect that may be further magnified
in the enriched-disease FIT+ population.15
We believe the results of our analysis are strengthened by the
specific setting in which it was performed. First, patients partici-
pating in organised screening programmes are actively invited,
so that selection bias due to symptoms is minimised. Second,
FIT positivity homogenises the expected prevalence of disease,
producing an ideal background to assess endoscopist perform-
ance. Third, organised programmes exploit sophisticated soft-
ware that continuously monitors the performance of the
operators/centres at any level, and audits completeness of endo-
scopic and histological data, so that internal bias is unlikely to
occur.7 Fourth, although some of the endoscopist-related/
centre-related data were collected prospectively, the endoscopic/
histological data in our FIT programmes was collected retro-
spectively, so that the endoscopist’s performance could not be
affected by the psychological awareness of participating in an
ADR-based study, the so-called Hawthorne effect.43 Fifth, dif-
ferent from the UK screening programme, there is no qualifying
examination for Italian endoscopists to participate in the Italian
organised screening programmes.17 Thus, our study reflects the
performance that may be expected in community-based
endoscopy.
There are limitations to this analysis. Only 44 out of 107
screening programmes ongoing in Italy took part in the study;
that cannot, therefore, be representative of all Italian pro-
grammes, in particular of those in Southern Italy. Nevertheless,
the large sample size and the population-based setting make our
findings applicable to other large scale FIT-based CRC screening
programmes. Moreover, CRC incidence rates are similar in
Northern as in Central Italy, while they are lower in the South.
Thus, the self-exclusion of those programmes increased the
homogeneity of the study, by reducing a potential source in
ADR variability represented by the different baseline prevalence
of the disease.
Since our study was based on volunteer participation by the
regional screening programmes, a selection bias cannot be, in
theory, excluded. However, participants were required to
provide data concerning all total colonoscopy performed among
people with a positive FIT result over a prespecified calendar
interval. So, as no selection of the examinations to be included
in the central data base could be performed by the endoscopists,
it seems unlikely that selection bias could affect the main results
of our analysis.
We adopted ADR and CIR as surrogate indicators of the
quality of colonoscopy, although the ultimate parameter of such
quality remains the risk of postcolonoscopy CRC. However,
both incidence and mortality of postcolonoscopy CRC have
been strictly associated with ADR.13 44
We did not systematically collect the colonoscopy withdrawal
time or certain technical aspects of colonoscopy, such as rectal
retroflexion, the use of antispasmodic drugs or the dose of seda-
tives. However, there is no specific policy in Italian programmes
—as well as in the European guidelines on the Quality of CRC
screening45—to collect these data. Incomplete data on some
variables may reflect selection bias from the most dedicated
endoscopists.
We did not prospectively test whether interventions targeted
at improving the identified predictors would result in an
increased ADR. However, simple organisational interventions
have already been shown to result in significant improvement in
the quality of colonoscopy.46
We included in our analysis only the first colonoscopy after a
positive FIT, thereby excluding the subsequent procedures sched-
uled to remove polyps that were judged not to be immediately
treatable. This may have caused an underestimation of ADR and
possibly an imbalance between endoscopists with different levels
of operative skills. However, the detection of adenomas at colon-
oscopies following negative exams was very low, accounting for a
0.3% increase of the ADR overall, without any significant differ-
ences according to endoscopist characteristics (data not shown).
Finally, our database did not provide accurate information to
assess predictors of colonoscopy-related adverse events, due to
the lack of a reporting policy for these events within organised
screening programme.
In conclusion, our study showed an adequate average level of
colonoscopy quality within a nationwide organised FIT screen-
ing programme. The observed variability among endoscopists
was affected by patient-related, endoscopist-related and
centre-related characteristics. Policies addressing the bowel
cleansing regimens, retraining for non-GI endoscopists, avail-
ability of dedicated screening sessions and moderate use of sed-
ation should improve the quality of colonoscopy in this setting.
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